Huaren Pharmaceutical Co Ltd (300110) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Huaren Pharmaceutical Co Ltd (300110) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥86.78 Million ≈ $12.70 Million USD) by net assets (CN¥1.43 Billion ≈ $208.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Huaren Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Huaren Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Huaren Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Huaren Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huaren Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Acacia Research Corporation NASDAQ:ACTG	0.006x
Tianjin Jieqiang Power Equipment Co SHE:300875	-0.007x
Nuveen Variable Rate Preferred & Income Fund NYSE:NPFD	0.113x
Hillstone Networks Co Ltd SHG:688030	-0.042x
AngioDynamics Inc NASDAQ:ANGO	-0.018x
Kneat.com Inc TO:KSI	-0.047x
Deutsche Beteiligungs AG XETRA:DBAN	-0.020x
Three Stars NM SHG:603578	0.164x

Annual Cash Flow Conversion Efficiency for Huaren Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Huaren Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300110 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥909.06 Million ≈ $133.02 Million	CN¥390.23 Million ≈ $57.10 Million	0.429x	+82.96%
2024-12-31	CN¥1.37 Billion ≈ $201.05 Million	CN¥322.36 Million ≈ $47.17 Million	0.235x	+112.36%
2023-12-31	CN¥2.77 Billion ≈ $404.75 Million	CN¥305.60 Million ≈ $44.72 Million	0.110x	+31.77%
2022-12-31	CN¥2.60 Billion ≈ $380.43 Million	CN¥217.98 Million ≈ $31.90 Million	0.084x	+135.41%
2021-12-31	CN¥2.44 Billion ≈ $357.55 Million	CN¥-578.52 Million ≈ $-84.66 Million	-0.237x	-5034.78%
2020-12-31	CN¥2.33 Billion ≈ $340.88 Million	CN¥-10.74 Million ≈ $-1.57 Million	-0.005x	-103.35%
2019-12-31	CN¥2.25 Billion ≈ $329.02 Million	CN¥309.33 Million ≈ $45.26 Million	0.138x	+21.89%
2018-12-31	CN¥2.25 Billion ≈ $329.72 Million	CN¥254.32 Million ≈ $37.21 Million	0.113x	-17.22%
2017-12-31	CN¥1.55 Billion ≈ $226.55 Million	CN¥211.08 Million ≈ $30.89 Million	0.136x	+14.53%
2016-12-31	CN¥1.53 Billion ≈ $223.29 Million	CN¥181.65 Million ≈ $26.58 Million	0.119x	+813.41%
2015-12-31	CN¥1.44 Billion ≈ $210.71 Million	CN¥18.77 Million ≈ $2.75 Million	0.013x	-70.59%
2014-12-31	CN¥1.48 Billion ≈ $216.53 Million	CN¥65.56 Million ≈ $9.59 Million	0.044x	+62.55%
2013-12-31	CN¥1.46 Billion ≈ $213.55 Million	CN¥39.78 Million ≈ $5.82 Million	0.027x	-63.29%
2012-12-31	CN¥1.34 Billion ≈ $195.97 Million	CN¥99.44 Million ≈ $14.55 Million	0.074x	+48.64%
2011-12-31	CN¥1.19 Billion ≈ $174.38 Million	CN¥59.53 Million ≈ $8.71 Million	0.050x	-28.93%
2010-12-31	CN¥1.10 Billion ≈ $161.57 Million	CN¥77.61 Million ≈ $11.36 Million	0.070x	-42.90%
2009-12-31	CN¥313.80 Million ≈ $45.92 Million	CN¥38.63 Million ≈ $5.65 Million	0.123x	-52.47%
2008-12-31	CN¥221.03 Million ≈ $32.34 Million	CN¥57.24 Million ≈ $8.38 Million	0.259x	+524.40%
2007-12-31	CN¥184.68 Million ≈ $27.02 Million	CN¥7.66 Million ≈ $1.12 Million	0.041x	--

About Huaren Pharmaceutical Co Ltd

SHE:300110 China Drug Manufacturers - Specialty & Generic

Market Cap

$448.06 Million

CN¥3.06 Billion CNY

Market Cap Rank

#13006 Global

#3871 in China

Share Price

CN¥2.59

Change (1 day)

+0.78%

52-Week Range

CN¥2.57 - CN¥3.70

All Time High

CN¥13.46